Persistent URL of this record https://hdl.handle.net/1887/3565052
Documents
-
- Download
- 1-s2.0-S0959804922003021-main
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Nazartinib for treatment-naive EGFR-mutant non-small cell lung cancer: results of a phase 2, single-arm, open-label study
- All authors
- Tan, D.S.W.; Kim, S.W.; Aix, S.P.; Sequist, L.V.; Smit, E.F.; Yang, J.C.H.; Hida, T.; Toyozawa, R.; Felip, E.; Wolf, J.; Grohe, C.; Leighl, N.B.; Riely, G.; Cui, X.M.; Zou, M.K.; Ghebremariam, S.; O'Sullivan-Djentuh, L.; Belli, R.; Giovannini, M.; Kim, D.W.
- Date
- 2022-07-07
- Journal
- European Journal of Cancer
- Volume
- 172
- Pages
- 276 - 286